Additional ADCs comprise polatuzumab vedotin-piiq, Brentuximab vedotin, tisotumab vedotin-tftv, gemtuzumab ozogamicin, Enfortumab vedotin, Sacituzumab govitecan, Trastuzumab deruxtecan, loncastuximab tesirine-lpyl, Moxetumomab pasudotox, belantamab mafodotin-blmf, and inotuzumab ozogamicin
Combinations with vitamin C require careful pH management to prevent copper-induced oxidation, while retinol combinations may increase sensitivity requiring gradual introduction protocols
Unlike an additive effect (1+1=2), synergy produces a result of the type 1+1=3
Yes this is one of the strongest established applications of metabolomics in drug discovery
On the flip side, optimal selenium intake bolsters GPx, enhancing resistance to stressors